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In development, embryonic ectoderm differentiates
into neuroectoderm and surface ectoderm using
poorly understood mechanisms. Here, we show that
the transcription factor OVOL2 maintains the tran-
scriptional programof humancorneal epitheliumcells
(CECs), a derivative of the surface ectoderm, and that
OVOL2 may regulate the differential transcriptional
programs of the two lineages. A functional screen
identified OVOL2 as a repressor of mesenchymal
genes to maintain CECs. Transduction of OVOL2
with several other transcription factors induced the
transcriptional program of CECs in fibroblasts. More-
over, neuroectoderm derivatives were found to ex-
press mesenchymal genes, and OVOL2 alone could
induce the transcriptional program of CECs in neural
progenitors by repressing these genes while acti-
vating epithelial genes. Our data suggest that the
difference between the transcriptional programs of
some neuroectoderm- and surface ectoderm-deriva-
tive cells may be regulated in part by a recipro-
cally repressive mechanism between epithelial and
mesenchymal genes, as seen in epithelial-to-mesen-
chymal transition.
INTRODUCTION
In development, embryonic ectoderm differentiates into either
neuroectoderm or a non-neural ectoderm, such as surface ecto-
derm (Ozair et al., 2013), which gives rise to epidermal tissues
including the corneal epithelium (Ordonez and Di Girolamo,Ce
This is an open access article und2012). However, the mechanism regulating specification be-
tween these lineages is largely unknown. Transcription factors
(TFs) are crucial in lineage specification, as they regulate cell-
type-specific transcriptional programs (Lee and Young, 2013).
There are more than 2,000 TFs in the mammalian genome and
hundreds are differentially expressed in each cell type. A handful
of TFs, or master TFs, are able to regulate a whole transcriptional
program (e.g., direct reprogramming) and play a central role in
determining cellular identity (Lee and Young, 2013). The tran-
scriptional program of neuroectoderm requires the paired box
TF PAX6 (Zhang et al., 2010), which is also necessary for that
of corneal epithelial cells (CECs) (Ouyang et al., 2014). The fact
that these two closely related lineages require a common TF
implies that a substantial part of their maintenance mechanisms
is shared. TFs for neuroectodermal derivatives, such as neural
progenitors, have been studied extensively (Xu et al., 2015) but
those of human CECs are relatively unknown.
In the present study, we identified OVOL2 as a new TF that
maintains CECs. OVOL2 functioned by mainly repressing mesen-
chymal genes. We also found that neuroectoderm lineage cells
expressed mesenchymal genes, of which repression by OVOL2
and activation of epithelial genes could induce the transcriptional
program of CECs. This process was likely regulated by a recipro-
cally repressingmechanismbetween epithelial andmesenchymal
genes, as seen in epithelial-to-mesenchymal transition (EMT).
These results should shed new light on the transcriptional pro-
gramsdetermining neuroectodermand surface ectoderm lineage.
RESULTS
TFs that Inhibit iPSC Induction in CECs Tend to Regulate
Epithelial Development
Because TFs that strongly maintain cell-type-specific transcrip-
tional programs are reported to inhibit the dedifferentiationll Reports 15, 1359–1368, May 10, 2016 ª 2016 The Authors 1359
er the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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Figure 1. TFs that Inhibit iPSC Induction
in CECs Tend to Regulate Epithelial Devel-
opment
(A) Schematic figure of the iPSC induction assay.
(B) The ratio of AP-positive colonies induced from
CECs (two independent experiments). OSKM with
empty vector = 1.
(C) GO term analysis by dividing whole TFs into
five groups according to the inhibition order. TFs
involved in epithelial lineage development were
enriched in TFs 1–30.
See also Figure S1 and Table S1.triggered by induced pluripotent stem cell (iPSC) induction
(Hanna et al., 2008; Hikichi et al., 2013), we sought TFs that
inhibit iPSC induction in CECs to identify important TFs for
CECs. Microarray data of human CECs and conjunctival
epithelial cells were compared with those of cardiomyocytes, fi-
broblasts, and embryonic stem cells (ESCs) from a published
database. We selected TFs that had at least 4-fold higher
expression in CECs compared with the other cell types, which
resulted in 145 candidate TFs. We coinfected each TF with
OCT4, SOX2, KLF4, and MYC (OSKM) in a retrovirus and as-
sayed inhibitory effects on iPSC colony numbers (Figure 1A).
We arranged the TFs in order of the relative number of iPSC col-
onies (Figures 1B and S1A; Table S1). There was no correlation in
the relative number of iPSC colonies for CECs and human fibro-
blasts using the same TFs, suggesting that the results reflected
a cell-type-specific event (Figures S1B–S1D; Table S1). Using
these data of CECs, we divided the 145 TFs into five groups ac-
cording to their inhibitory effects on iPSC induction and analyzed
the enrichment of Gene Ontology (GO) terms in each group. Only
in the strongest inhibiting TF group, did we observe signif-
icant enrichment of many development-related terms including
epithelial development (Figures 1C and S1E), suggesting that
TFs that inhibited iPSC induction also tended to regulate differ-
entiation, including possibly that of epithelial lineage.
Combined Overexpression of Inhibitory TFs Induced the
Transcriptional Program of CECs in Human Fibroblasts
Because important TFs are often capable of inducing a cell-type-
specific transcriptional program (Xu et al., 2015), we next asked
whether TFs that inhibited iPSC induction could induce the tran-
scriptional program of CECs.We considered the top 21 inhibiting
TFs from the above analysis along with PAX6 and KLF4, which1360 Cell Reports 15, 1359–1368, May 10, 2016are known to maintain CECs (Swamyna-
than et al., 2007; Ouyang et al., 2014)
and TP63 and MYC, resulting in a pool
of 25 TFs. When these 25 TFs were over-
expressed in human fibroblasts by lenti-
virus vector, fibroblasts started to gather
together and show a morphology that
resembled epithelial cells by day 10 (Fig-
ure 2A). We found that overexpression of
the 25 TFs upregulated several CEC-spe-
cific genes, including CDH1, KRT3, and
ALDH3A1 (Figure 2B). To find which TFsare necessary for the induction of these genes, we next
removed individual factors from the pool and analyzed gene
activation at 10 days after infection. In particular, removal of
OVOL2 decreased CDH1, whereas removal of either PAX6 or
KLF4 reduced KRT3. In addition, removal of SOX9 abolished
ALDH3A1 (Figure 2B), suggesting that these four TFs are
required for the activation of CEC-specific genes. Consistently,
simultaneous overexpression of the four TFs in fibroblasts
greatly upregulated CEC-specific genes (Figure S2A). To further
enhance the activation of CEC-specific genes, we added TP63
and MYC, because they are thought to promote proliferation in
CECs (Pellegrini et al., 2001; Perry et al., 2013), and because
cell proliferation is likely to facilitate reprogramming, presumably
by allowing TFs to access DNA during DNA replication (Xu et al.,
2015). Overexpression of the six TFs in fibroblasts induced cells
with epithelial morphology that expressed E-cadherin, K3, and
K12 (Schermer et al., 1986) (Figures 2C and S2B). These cells
expressed higher levels of CEC-specific genes (Figure S2A),
suggesting the six TFs were able to induce the transcriptional
program of CECs to some extent.
Approximately 5% of fibroblasts with the six TFs expressed
CLDN1, a membrane protein specifically expressed in CECs
(Yoshida et al., 2009) (Figure 2D). We next sorted CLDN1-posi-
tive cells (hereafter 6TFs-fib) by fluorescence-activated cell sort-
ing (FACS) using anti-CLDN1 antibody. 6TFs-fib expressed
CEC-specific genes including KRT12 at comparable levels as
those in human primary CECs, while fibroblast-specific genes
were suppressed (Figure 2E). Microarray analyses followed
by unsupervised hierarchical analyses indicated that 6TFs-fib
clustered with primary CECs but separated from fibroblasts (Fig-
ure 2F). Indeed, genes upregulated or downregulated in 6TFs-fib
included a significant number of genes with highly different
expression levels between primary CECs and fibroblasts (Fig-
ures S2C and S2D). Moreover, principle component analysis
(PCA) revealed that 6TFs-fib were mapped closer to primary
CECs and distant from fibroblasts (Figure S2E), mostly because
of the expression of genes involved in development or differen-
tiation (Tables S1 and S2). This indicates that these six TFs
were able to at least partially induce the transcriptional program
of CECs.
In addition to global gene expression, the landscape of nucle-
osome-free regions highly reflects differences in cell lineages,
likely because lineage-specific TFs bind and regulate gene
expressions through these regions (Stergachis et al., 2013).
Accordingly, we performed assay for transposase-accessible
chromatin with high throughput sequencing (ATAC-seq), which
provides genome-wide information on nucleosome-free regions
(Buenrostro et al., 2013), using CECs, 6TFs-fib, and fibroblasts.
Notably, in some CEC-specific genes, peaks in the promoter re-
gions seen in primary CECs but not in fibroblasts appeared in
6TFs-fib, whereas peaks in the promoter regions of some fibro-
blast-specific genes seen in fibroblasts disappeared in 6TFs-fib
(Figures 2G and S2F). Global comparison of peaks indicated that
17.3% of peaks that appeared in 6TFs-fib (6TFs-fib presence
peaks) were primary CEC-specific peaks, while 61.3% of peaks
that disappeared (6TFs-fib absence peaks) were fibroblast-spe-
cific peaks (Figures 2H and S2G), indicating that the six TFs were
able to at least partially induce a CEC landscape of nucleosome-
free regions in fibroblasts.
OVOL2 Repressed Mesenchymal Genes in CECs
Because the functions of PAX6 and KLF4 in CEC maintenance
have already been reported (Graw, 2003; Swamynathan et al.,
2007), we next examined howOVOL2 contributes to maintaining
the transcriptional program of CECs using small interfering
RNA (siRNA) in primary CECs. OVOL2 knockdown reduced the
expression of CEC-specific genes (Figure 3A) and keratin 12 pro-
tein in primary CECs (Figure 3B). Morphologically, CECs with
OVOL2 knockdown became elongated fibroblastic cells (Fig-
ure 3C). Immunocytochemistry of CECs with OVOL2 knockdown
showed a reduction of K12 and E-cadherin proteins (Figure 3D).
Moreover, OVOL2 knockdown significantly reduced the barrier
function of primary CECs as measured by transepithelial electri-
cal resistance (TER) (Figures 3E and 3F), suggesting that OVOL2
functionally maintains CECs. Global expression analyses be-
tween CECs and CECs treated with siOVOL2 by microarray
revealed that among the 42,545 genes analyzed, 805 genes
were differentially expressed by >1.5-fold, and 320 genes were
upregulated and 485 genes were downregulated in CECs with
siOVOL2 (Figure 3G). Downregulated genes enriched GO terms
related to epithelial functions (Figure 3H), whereas upregulated
genes were not significantly associated with any terms.
To gain insight into the function of OVOL2, we analyzed TF
motif enrichment using the ATAC-seq data. In sequences among
the fibroblast-specific peaks and the 6TFs-fib absence peaks,
the OVOL2 motif (CCGTTA) (Watanabe et al., 2014) was signifi-
cantly enriched (Figure S3A; Table S3A). Moreover, genes within
the 6TFs-fib absence peaks and containing the OVOL2 motif
enriched GO terms related to mesenchymal cells (Figure S3B).
To address whether OVOL2 represses mesenchymal genes inCECs, we examinedOVOL2 effects in response to TGF-b, whose
activation leads to a loss of CEC identity through EMT (Yamben
et al., 2013). We used the doxycycline (Dox)-inducible system
to conditionally overexpress OVOL2 in primary CECs. While
CECs treated with TGF-b changed to fibroblastic morphology
(Figure S3C) and showed an upregulation of mesenchymal
genes (Figure S3D), OVOL2 overexpression at least partially
blocked the morphological change and significantly repressed
the upregulation (Figures S3C and S3D), indicating that OVOL2
represses mesenchymal genes in CECs. Indeed, in OVOL2
knockdown CECs, mesenchymal genes such as ZEB1 and
ZEB2, two well-known mesenchymal genes (De Craene and
Berx, 2013), were upregulated (Figure S3E). Chromatin immu-
noprecipitation sequencing (ChIP-seq) analysis using CECs
showed OVOL2 peaks on ZEB1 and ZEB2 (Figure 3I; Table
S3B), suggesting that OVOL2 bound and repressed fibroblast-
specific genes, particularly those with mesenchymal function.
In accordance with this result, recent reports showed that
OVOL2 is a strong epithelial regulator that maintains transcrip-
tional programs in epidermal keratinocytes and mammary
epithelial cells by repressing ZEB1 and ZEB2 (Lee et al., 2014;
Watanabe et al., 2014). At the same time, overexpression of
ZEB1 in CECs partially repressed the expression level of CDH1
(Figure 3J), consistent with its effect in other epithelial cells (Shir-
akihara et al., 2007), and E-cadherin expression was weak in
CECs overexpressing ZEB1 or ZEB2 compared to the control
(Figure 3K). Additionally, barrier function assay demonstrated
that CECs overexpressing ZEB1 or ZEB2 reduced the TER
compared to the control (Figure 3L). These results suggested
that OVOL2 maintains CECs in part by repressing mesenchymal
genes such as ZEB genes.
OVOL2 Induced the Transcriptional Program of CECs in
Neural Progenitor Cells
Interestingly, OVOL2 knockdown in CECs derepressed not only
mesenchymal genes such as ZEB genes, but also neural progen-
itor cell (NPC)-specific genes including SOX2 (Figure S3E). ZEB
genes are required for neuroectoderm differentiation in vivo and
in vitro (Chng et al., 2010; Miyoshi et al., 2006). We meta-
analyzed published datasets of human cells and found that in
neuroectoderm and NPCs, some mesenchymal genes including
ZEB genes are highly expressed, whereas epithelial genes are
repressed (Figure 4A). This expression pattern was similar to
that of adipose-derived mesenchymal stem cells and fibroblasts
(Figure 4A), which are known to express mesenchymal genes
(Kfoury and Scadden, 2015). In contrast, in CECs and epidermal
keratinocytes, which are derived from surface ectoderm (Koster
and Roop, 2007), as well as in iPSCs and ESCs, which are
thought to be epithelial cells (De Craene and Berx, 2013), the
expression pattern was opposite; mesenchymal genes were
repressed whereas epithelial genes were highly expressed
(Figure 4A). We further meta-analyzed additional datasets of
mouse cells and confirmed similar expression patterns (higher
expression of mesenchymal genes; lower expression of epithe-
lial genes) in various cell types derived from neuroectoderm (Fig-
ures S4A and S4B). These results suggest that mesenchymal
genes might contribute to the maintenance of transcriptional
programs of neuroectoderm lineage cells, and epithelial genesCell Reports 15, 1359–1368, May 10, 2016 1361
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expressed in surface ectodermal lineage cells possibly repress
the transcriptional program of neuroectoderm cells by repres-
sing mesenchymal genes using a mechanism similar to that in
EMT (De Craene and Berx, 2013). We thus hypothesized that
OVOL2 regulates cell-type-specific transcriptional programs be-
tween CECs and NPCs, which we used as representative cell
types of surface ectoderm and neuroectoderm lineage, respec-
tively, through the reciprocally repressive mechanism between
epithelial and mesenchymal genes seen in EMT. To test this the-
ory, we overexpressed OVOL2 alone in NPCs and analyzed the
expression of CEC-specific genes. To our surprise, NPCs with
OVOL2 overexpression started to form cell-cell junctions much
like those in epithelial-like cells (Figure 4B). NPCs with OVOL2
overexpression exhibited a high expression of CEC-specific
genes (Krt12 and Aldh3a1) without any upregulation of Krt1 or
Krt10, while mesenchymal genes (Snai2 and Zeb2) were down-
regulated (Figures 4C and S4C). Furthermore, by microarray
analysis, we found that the expressions of most epithelial and
mesenchymal genes were reciprocated in NPCs with OVOL2
and NPCs alone, with epithelial genes upregulated and mesen-
chymal genes downregulated in the former (Figure 4D). In light
of the specificity of Krt12 expression (as well as the phenotype
of its knockout mice) seen only in corneal epithelium in the
body (Kao et al., 1996), the upregulation ofKrt12 byOVOL2 over-
expression suggests specific activation of the transcriptional
program of CECs. We considered whether this activation was
mediated, in part, by the repression of Zeb1 and Zeb2, because
both genes were quickly downregulated in NPC overexpressing
OVOL2 (Figure 4E), while at the same time Zeb1 overexpression
partially blocked the upregulation of Krt12 and Cdh1 (Figure 4F).
These results are consistent with our ChIP-seq data (Figure 3I)
and demonstrate that ZEB1/2 were OVOL2 targets. At the global
level, the upregulated and downregulated genes contained a
significant number of genes highly expressed in CECs and
NPCs, respectively (Figures S4D and S4E). These data indicated
that forced expression of OVOL2 in NPCs could at least
partially induce the transcriptional program of CECs by repres-
sing mesenchymal genes. Moreover, overexpression of Grhl2,
another epithelial TF (De Craene and Berx, 2013), induced
epithelial-like cells in NPCs (Figure S4F) with an expression pro-
file similar to that by OVOL2 overexpression (Figure S4G), sug-
gesting the repression of mesenchymal genes and activation
of epithelial genes (i.e., regulation of EMT-related genes) may
be sufficient to activate the transcriptional program of CECs.
Collectively, our data show that OVOL2 maintains the transcrip-
tional program of CECs by repressing mesenchymal genes to
maintain epithelial identity (Figure 4G). This result suggests thatFigure 2. Combined Overexpression of Inhibitory TFs Induced the Tran
(A) The morphology of neonatal human fibroblasts, fibroblasts transduced with G
(B) The effect of removing individual TFs from the pool of 25 TFs was examined
(C) Phase contrast and immunocytochemistry of K3, K12, and E-cadherin in fibr
(D) Fluorescence-activated cell sorting (FACS) analysis using Claudin 1 (CLDN1)
(E) Quantitative analysis of CEC-specific genes, fibroblast-specific genes, and end
using the unpaired t test and are shown as means ± SD. *p < 0.05, **p < 0.01.
(F) Unsupervised hierarchical analyses of global gene expression.
(G) ATAC-seq peaks in the promoter regions of CEC-specific genes and fibrobla
(H) Comparison of ATAC-seq peaks at the global level. Numbers represent peak
See also Figure S2 and Table S2.differences between the transcriptional programs of some
surface ectoderm- and neuroectoderm-derivative cells may be
regulated in part by the reciprocally repressive mechanism
between epithelial and mesenchymal genes seen in EMT.
DISCUSSION
The identification of master TFs has advanced our understand-
ing of development and aided in therapeutic research (Lee and
Young, 2013). Previously, PAX6 was the only identified TF that
could induce CEC-lineage cells from a derivative of surface ecto-
derm (Ouyang et al., 2014). In the present work, we found PAX6
alone did not induce the transcriptional program of CECs in
fibroblasts, whose lineage is presumably distant from surface
ectoderm (Kfoury and Scadden, 2015) (Figure S2A). Instead,
cotransduction with OVOL2, an epithelial regulator, successfully
induced the transcriptional program. Overexpression of OVOL2
alone in fibroblasts, however, was not sufficient for the induction
(Figure S2A) suggesting that PAX6 and OVOL2 may coopera-
tively activate the transcriptional program of CECs. Indeed, over-
expression of OVOL2 with other TFs could induce CEC-like cells
in a cell type (oral mucosal epithelial cell) other than fibroblasts
(Figure S4H), suggesting that OVOL2 could provide important
clues for future therapeutics.
Our data showed that OVOL2 maintained the transcriptional
program of CECs by repressing mesenchymal genes, a function
that may explain differences in the transcriptional programs of
neuroectoderm and surface ectoderm. Several lines of evidence
support this scheme. In Ovol2 knockout embryo, surface ecto-
derm is reduced while neuroectoderm is expanded (Mackay
et al., 2006). In addition, in an ESC differentiation system, Ovol2
knockdown enhances neuroectoderm differentiation, and Ovol2
overexpression in chick embryo inhibits neuroectoderm differen-
tiation (Mackayet al., 2006;Zhanget al., 2013).On theother hand,
mesenchymal genes are required for the transcriptional program
of neuroectoderm, as knockout of ZEB1 and ZEB2 in embryo
causes defects in neural tube in which Sox2 (a TF gene required
for neuroectoderm) expression is repressed (Miyoshi et al.,
2006), andZEB2knockdown inESCssuppressesneuroectoderm
differentiation (Chng et al., 2010). Several other studies using
ESCshave also indicated the involvement ofmesenchymal genes
in neuroectoderm differentiation (Di Micco et al., 2014; Du et al.,
2013;Gill et al., 2011).Moreover, our analysis showed that various
neuroectoderm derivatives expressed high levels of mesen-
chymal genes, while surface ectoderm derivatives instead ex-
pressed epithelial genes highly. These observations suggest
that mesenchymal and epithelial genes, which might segregatescriptional Program of CECs in Human Fibroblasts
FP, and fibroblasts transduced with 25 TFs. Scale bars, 200 mm.
by qRT-PCR (all n = 4). Data are shown as means ± SD.
oblasts and fibroblasts with 6 TFs (6TFs-fib). Scale bars, 20 mm.
antibody.
ogenousOVOL2 and PAX6 in the indicated cells (all n = 4). Data were analyzed
stic-specific genes (all n = 4).
numbers detected by Hotspot software.
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neuroectoderm and surface ectoderm in early development, may
still regulate the transcriptional programs in some derivative cells
of these lineages. Recent reports have demonstrated that OVOL2
maintains epidermal keratinocytes and mammary epithelial cells
by repressing mesenchymal genes, suggesting it an epithelial
regulator (Lee et al., 2014; Watanabe et al., 2014). Our data
showed that in CECs, OVOL2 activates epithelial genes by re-
pressing mesenchymal genes whose expression might promote
neuroectoderm lineage. Similarly to other epithelial cell types,
OVOL2bound toandcould repressZEB1andZEB2 inCECs, sug-
gesting that both of these genes are direct targets of OVOL2.
Because upregulation of ZEB1 and ZEB2 was modest in OVOL2
knockdown, these two genes might constitute only a subgroup
of causative genes for the loss of epithelial identity, as seen in
keratinocytes (Lee et al., 2014). Taken together, we propose
that OVOL2 might regulate differences in the transcriptional pro-
grams between surface ectoderm and neuroectoderm through
a reciprocally repressing mechanism between epithelial and
mesenchymal genes, as seen in the switch-like reversion of the
expression status in EMT.
EXPERIMENTAL PROCEDURES
Sample Collection and Cell Preparation
Human normal corneal tissues were obtained from donors from SightLife
exclusively for research purposes and human normal conjunctival tissues
from two patients who received conjunctival-chalasis surgery. Human oral
mucosal tissues were obtained from healthy volunteers, and superfluous tis-
sue was obtained from patients undergoing oral surgery. All patients provided
informed consent following the guidelines of the Kyoto Prefectural University
of Medicine Ethics Committee. CECs were isolated by treatment with 1,000
protease units (PU)/ml of dispase (Dispase type II; Godo Shusei) at 4C over-
night and TrypLE Express (Life Technologies) at 4C for 30 min. Isolated pri-
mary CECs were seeded on a 60-mm dish or 6-well plate coated with 0.1%
gelatin and were cultured in CEC medium, which consisted of DMEM and
Ham’s F-12 media (1:1 mixture) (Life Technologies) containing B27-supple-
ment (Life Technologies), Rho-kinase (ROCK) inhibitor (10 mM) (Nacalai
Tesque), epidermal growth factor (EGF) (10 ng/ml) (Life Technologies), Epigal-
locatechin gallate (10 ng/ml) (Sigma), and penicillin-streptomycin (50 IU/ml)
(Nakalai Tesque), at 37C in a 5% CO2 incubator and then used for the
following experiments after one passage using TrypLE Express at double dilu-
tion at room temperature upon reaching sub-confluence. For the functional
screening of transcription factors, CECs from the same donors at the time ofFigure 3. OVOL2 Repressed Mesenchymal Genes in CECs
(A) Knockdown ofOVOL2 using siRNA (siOVOL2) in CECs and downregulation of C
unpaired t test and are shown as means ± SD. **p < 0.01.
(B) Western blotting of K12 in primary CECs treated with two siRNAs for OVOL2
(C) The morphology of CECs and CECs treated with siOVOL2. Scale bars, 20 mm
(D) Immunocytochemistry of K12 and E-cadherin in CECs and CECs treated with
(E) Barrier function was assessed by measuring transepithelial electrical resistan
(F) Barrier function assay demonstrated that siRNA for OVOL2 reduced the TER co
technical triplicates are shown as means ± SD. Data were analyzed using the un
(G) Scatter plots analysis of gene expressions between CECs and CECs treated
(485 genes).
(H) GO analysis showed that epithelial-related genes were enriched in DOWN ge
(I) ChIP-seq analysis of OVOL2 in the CECs.
(J) Quantitative analysis of CDH1 in the CECs and CECs overexpressing ZEB1 or
means ± SD. *p < 0.05. GFP-transduced CECs were used as control.
(K) Immunocytochemistry of CDH1 in CECs and CECs overexpressing ZEB1 or
(L) Barrier function assay demonstrated that overexpression of ZEB1 or ZEB2
Representative results of four independent experimentswith technical triplicates ar
See also Figure S3 and Table S3.first passage were stocked at150C until use. Neonatal human dermal fibro-
blasts were purchased from Lonza. NPCs have been previously established
and cultured in N2B27 media with fibroblast growth factor (FGF) 2 and EGF
(Conti et al., 2005; Hikichi et al., 2013).
Retroviral Preparation
Plat-GP cells were seeded at a density of 2.0 3 106 cells on a 10-cm dish in
10 ml of DMEM (Nacalai Tesque) with 10% FBS. Retroviral (6 mg) and 3 mg
of VSV-G vector DNAs were transfected by using 27 ml of FuGENE 6 (Prom-
ega). A mixture of the retroviral supernatant and the cell culture medium in
equal amounts was added to the cell in the presence of 5 mg/ml polybrene
on the plate. The cell plate was set up in the centrifuge at 35C and then centri-
fuged for 30 min at 800 3 g.
iPSC Induction Assay
Yamanaka factors (OCT3/4, SOX2, KLF4, and cMYC) with each candidate TF
(total, 5 TFs) were transduced by retroviruses to the CECs seeded at a density
of 0.75 to 1.0 3 104 cells on a 6-well plate. At day 2, mitomycin-treated SNL
feeder cells were added at a density of 5 3 105 cells, and the medium was
replaced with CEC medium and 0.5% FBS. After day 6, the medium was
switched to Primate ES cell medium (ReproCELL) supplemented with 20 ng/ml
FGF2and changedeachdayuntil day21. iPSCcolonieswere stainedbyalkaline
phosphatase (AP) Kit (Muto Pure Chemicals).
Induction of the Transcriptional Program of CECs in Fibroblasts
A combination of TFs was transduced by lentivirus or retrovirus to fibroblasts
seeded at a density of 6.03 104 cells on a 6-well plate. After 3 days of infection,
the medium was switched to CEC medium, and the cells were cultured until
day 10. RNA was extracted using the RNeasy Mini Kit. Primers listed in
Table S4 were used for qRT-PCR.
siRNA Treatment
ON-TARGETplus siRNA or siRNA-SMARTpool (25 nM) (GE Healthcare) was
transfected into the primary CECs at a density of 2.5 3 105 cells on a
24-well plate using 2.5 ml of DharmaFECT 4 siRNA Transfection Reagent
(GE Healthcare). The cells were harvested at 48 hr after the transfection.
Barrier Functional Assay
Cells were cultured on 12-well porous membrane filters (Transwell, 0.4 mm
pore; Corning) at 5.03 105 cells. TER between the upper and lower chambers
was assessed using a volt-ohmmeter (EVOM;World Precision Instruments) as
previously described (Kitazawa et al., 2013).
Induction of the Transcriptional Program of CECs in NPCs
Retroviruses were transduced to NPCs at 5.03 103 cells on a 6-well plate, and
the next day 1 mg/ml puromycin or 500 mg/ml neomycin was added. For theEC-specific genes based on qRT-PCR (all n = 4). Data were analyzed using the
.
.
siOVOL2. Scale bars, 20 mm.
ce (TER) with a volt-ohm meter.
mpared to control. Representative results of two independent experimentswith
paired t test. **p < 0.01.
with siOVOL2 found upregulated genes (320 genes) and downregulated genes
nes.
ZEB2 (all n = 3). Data were analyzed using the unpaired t test and are shown as
ZEB2. GFP-transduced CECs were used as control.
in CECs reduced the TER compared to the control (GFP-transduced CECs).
e shownasmeans±SD.Datawere analyzedusing the unpaired t test. **p <0.01.
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Figure 4. OVOL2 Overexpression Induced the Transcriptional Program of CECs in Neural Progenitor Cells by Regulating Genes Involved
in EMT
(A) Microarray analyses of EMT-related genes among CECs, epidermal keratinocytes (EDK), adipose-derived stem cells (ASC), dermal fibroblasts (HDF), NPCs,
neuroectoderm (NE), iPSCs, and ESCs.
(B–D) Ten days after viral infection. (B) The morphology of NPCs overexpressing OVOL2. Scale bars, 20 mm. (C) Quantitative analysis of CEC-specific genes and
NPC-specific genes (all n = 4). Data were analyzed using the unpaired t test and are shown as means ± SD. **p < 0.01. (D) The expressions of EMT-related genes
reciprocate with the overexpression of OVOL2. Two individual experiments were performed.
(E and F) Three days after viral infection. Data were analyzed using the unpaired t test and are shown as means ± SD. **p < 0.01. (E) Zeb1 and Zeb2 were
downregulated in NPC overexpressing OVOL2. (F) OVOL2 activated, but Zeb1 repressed Krt12 and Cdh1 gene expressions in NPC.
(G) Schematic figure of the mechanism shows how the transcriptional profile between CEC and NPC is distinguished.
See also Figures S3 and S4.
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samples of 10 days after transduction, at 3 days after transduction the
culture medium was switched to N2B27 medium with EGF but without FGF
and cultured 7 days.
Statistics
Unpaired t tests were used for all qRT-PCR analyses. For the binding motif
analysis of OVOL2 between CECs and fibroblasts, Fisher’s exact test was
used. Pearson’s correlation coefficient was used for comparisons of iPSC
induction activity between CECs and fibroblasts. All statistical results were
verified independently using the Ekuseru-Toukei 2012 (Social Survey
Research Information), and the hypergeometric distribution was analyzed
using Keisan online calculator (http://keisan.casio.com).
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